Compositions and methods for gene delivery to the airways and/or lungs
AssigneeKrystal Biotech, Inc.
InventorsSuma KRISHNAN, Trevor Parry, Pooja Agarwal, Sara Artusi, Mladen Yovchev
Life of this patent
Estimating the term…
Loading patent…
AssigneeKrystal Biotech, Inc.
InventorsSuma KRISHNAN, Trevor Parry, Pooja Agarwal, Sara Artusi, Mladen Yovchev
Estimating the term…
The present disclosure provides recombinant nucleic acids comprising one or more polynucleotides encoding a polypeptide (e.g., an inhaled therapeutic polypeptide, such as a human alpha-1-antitrypsin polypeptide); viruses comprising the recombinant nucleic acids; compositions and formulations comprising the recombinant nucleic acids and/or viruses; methods of their use (e.g., for delivering the polypeptide to one or more cells of the respiratory tract and/or for the treatment of a disease affecting the lungs, such as alpha-1-antitrypsin deficiency); and articles of manufacture or kits thereof.
-44. (canceled)
A pharmaceutical composition comprising:
-62. (canceled)
-81. (canceled)
(canceled)
(canceled)
(canceled)
A method of delivering a polypeptide to one or more cells of the respiratory tract of a subject, the method comprising administering to the subject a pharmaceutical composition comprising:
-110. (canceled)
Dependencies are inferred from the claim text.